Flu shot shortage also threatens backup line of defense

10/19/2004 | Wall Street Journal, The

In the absence of a scarce flu vaccine to treat expected illnesses this season, the health community faces a likely residual shortage of four antiviral drugs used to treat the flu once it has taken hold. The CDC is stockpiling drugs and planning quietly for their distribution at the same time it is trying to persuade drugmakers to increase production. Antiviral drugs include Roche's Tamiflu and GlaxoSmithKline's Relenza, as well as older treatments, including Forest Laboratories' Flumadine.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
Bridgewater, NJ